Coloplast A/S (0QBO.IL)

865.10 +0.50 (+0.06%) At close: 06:36PM BST

Coloplast A/S

Holtedam 1-3
Humlebæk 3050
Denmark
45 49 11 11 11
https://www.coloplast.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 14,700

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Kristian Villumsen	Pres & CEO	15.7M	N/A	1970
Mr. Anders Lonning-Skovgaard	Exec. VP & CFO	8M	N/A	1972
Mr. Allan Rasmussen	Exec. VP of Global Operations	7.1M	N/A	1967
Mr. Nicolai Buhl Andersen	Exec. VP of Innovation	6.8M	N/A	1969
Mr. Paul Marcun	Exec. VP of Growth	8.1M	N/A	1967
Mr. Thomas Barfod	Sr. Controller & Employees Representative Director	450k	N/A	1970
Ellen Bjurgert	VP of Investor Relations	N/A	N/A	N/A
Dennis Kaysen	Director of Corp. Communications	N/A	N/A	N/A
Dorthe Ronnau	Sr. VP of People & Culture	N/A	N/A	1966
Mr. Alain Morvan	Sr. VP of Sales Europe	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in DKK.

Description

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Corporate governance

Coloplast A/S’s ISS governance QualityScore as of 1 October 2023 is 3. The pillar scores are Audit: 1; Board: 4; Shareholder rights: 9; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.